Ocular Blood Flow and Glaucomatous Optic Neuropathy

Ocular Blood Flow and Glaucomatous Optic Neuropathy-1

Maneli Mozaffarieh Josef Flammer 2009 For the clinician and researcher, finding a mentor is probably the most crucial and least understood aspect of having a successful career. Unfortunately, in today’s self-conscious society it has become even more difficult to find that senior academic and clinician who conducts lectures, carries out advanced research and takes time to teach and train […]

Continue reading →

Glaucoma

Glaucoma-1

Editors Franz Grehn Robert Stamper 2009 This third volume in the series, Essentials of Ophthalmology, just like the first, seeks to bring the ophthalmic practitioner up to date in the important new advances or changes in glaucoma diagnosis or management that have occurred over the last ten years. The last decade has seen significant changes in our understanding of the pathophysiology […]

Continue reading →

Cataract Surgery in the Glaucoma Patient

Cataract Surgery in the Glaucoma Patient-1

Sandra Johnson Editor 2009 Cataract surgery is one of the most frequently performed procedures in the United States, and cataracts are a leading cause of visual impairment in the world. Glaucoma is also a very common eye disease with an expected 3.3 million Americans afflicted with primary open angle glaucoma by 2020. It is also a leading cause […]

Continue reading →

Cataract and Refractive Surgery

Cataract and Refractive Surgery-1

Editors Thomas Kohnen Douglas D. Koch 2009 We are pleased to share with our readers this Third Edition of Cataract and Refractive Surgery, less than three years from publication of the Second Edition. The dramatic pace of change in cataract and refractive surgery necessitates rapid publication of new material, with frequent updating of topics and introduction of new topics as they […]

Continue reading →

The Male Patient in Aesthetic Medicine

The Male Patient in Aesthetic Medicine-1

Mauricio de Maio • Berthold Rzany 2009 Men are different from women in many ways. Male aesthetics are different from female aesthetics. Most readers would agree with this statement. However, as the majority of our patients are still female, even cosmetic physicians may tend to treat their male patients like female patients. This can lead to dissatisfaction of […]

Continue reading →

Drug Product Development for the Back of the Eye

Drug Product Development for the Back of the Eye-1

Uday B. Kompella • Henry F. Edelhauser Editors 2011 Age-related macular degeneration and macular edema are major vision-threatening disorders of the back of the eye. The first therapeutic agents for treating these diseases, Macugen™ (Pfizer, a nucleic acid-based drug), Lucentis™ (Genentech; a protein drug), and Ozurdex™ (Allergan; a small molecule drug in a biodegradable, injectable implant) were approved by […]

Continue reading →

Ischemic Optic Neuropathies

Ischemic Optic Neuropathies -1

Sohan Singh Hayreh 2011 Ocular vascular occlusive disorders – that is, optic nerve ischemic disorders, retinal ischemic disorders and retinal venous occlusive disorders – collectively constitute the most common cause of acute visual loss. Nevertheless, information on these disorders has until recently been based primarily on clinical impressions, folklore, dogma, and “conventional wisdom” taught by one generation of ophthalmologists […]

Continue reading →

Ophthalmologic Drug Guide

Ophthalmologic Drug Guide-1

Douglas J. Rhee Kathryn A. Colby Lucia Sobrin Christopher J. Rapuano 2011 This pocket reference is designed to assist the eye care professional by providing current information on the ever-increasing number of ocular pharmacotherapeutics. Many different classes of medications are listed, oftentimes with pertinent facts.

Continue reading →